Ország: Egyesült Királyság
Nyelv: angol
Forrás: VMD (Veterinary Medicines Directorate)
Formic Acid
NOD Europe Ltd
QP53AG01
Formic Acid
Bee-hive strip
AVM-GSL - Authorised Veterinary Medicine – General Sales List
Bees
Ectoparasiticide
Authorized
2013-02-26
Revised: April 2018 AN: 01356/2017 SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MAQS Formic Acid 68.2g Beehive Strips for Honey Bees MAQS 68.2g Beehive Strips for Honey Bees (IT) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each strip contains: Active Substance: Formic Acid: 68.2g Excipients: For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Beehive strip. Each strip is an off-white to caramel coloured gel wrapped in white laminated biodegradable paper. Each strip is approximately 10 x 20 x 0.4 cm, weighing 146g 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Honey bee 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of Varroosis caused by VARROA DESTRUCTOR in honey bees (_Apis _ _mellifera_). 4.3 CONTRAINDICATIONS Do not use when peak temperatures are outside the range of 10 – 29.5°C on the day of application. See sections 4.4 and 4.5i also. Do not use for treatment of smaller colonies than those listed on the label _(single _ _or double brood-chamber, standard Langstroth equipment or equivalent full-sized_ _honey beehives, honey bee colony cluster covering a minimum of six frames, _ _(approximately 10,000 bees). A smaller colony might not provide sufficient _ _volume to achieve a tolerable formic acid concentration._ Page 1 of 10 Revised: April 2018 AN: 01356/2017 4.4 SPECIAL WARNINGS FOR TARGET SPECIES Take care to disturb the colony as little as possible during the application process. Treat all colonies in the apiary at the same time. Use according to local treatment recommendations, if available. The product should only be used as part of an integrated varroa control programme. It is highly recommended to monitor phoretic mite levels monthly during periods of brood rearing and treat when local thresholds are reached. To ensure sufficient efficacy the product should be used when outside temperatures exceed 10°C. See the temperature range given in section 4.3 “Contraindications”. 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTION Olvassa el a teljes dokumentumot